Molecular pharmacology
and biomarkers
Upon determination of the optimal conditions of use of a novel compound, the next challenge is to facilitate and strengthen its progress through the drug development process towards the clinic. This translational research is based on the discovery of molecular biomarkers of the efficacy of treatment.
|
Pharmaco-imaging
Pharmaco-imaging is the marriage between imaging and pharmacology that provides additional information that could not otherwise be obtained using traditional techniques. It allows for a more precise, faster and direct translation of data from a preclinical to clinical context. The development of techniques useful for pharmaco-imaging are fully integrated in Oncodesign’s R&D axes.
|
PK/PD relationship
The aim of this phase is to optimize the pharmacokinetic and pharmacodynamic parameters for the clinical development of an anticancer drug, which may help reduce the risks and costs of subsequent human trials.
|
Home
Back
Top